FDA Strengthens Warnings On Amgen, J&J Anemia Drugs
The U.S. Food and Drug Administration on Friday recommended stricter dosing guidelines for three Amgen Inc. and Johnson & Johnson anemia drugs, warning that they could increase the risk of stroke,...To view the full article, register now.
Already a subscriber? Click here to view full article